Dong Hua

1.6k total citations
23 papers, 1.3k citations indexed

About

Dong Hua is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong Hua has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Dong Hua's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Dong Hua is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Dong Hua collaborates with scholars based in China and United States. Dong Hua's co-authors include Yuan Yin, Zhaohui Huang, Zehua Bian, Jiwei Zhang, Yaling Hu, Bojian Fei, Yong Mao, Mingxu Song, Leyuan Zhou and Bin-Bin Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Oncotarget.

In The Last Decade

Dong Hua

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by Dong Hua

Since Specialization

Citations

This map shows the geographic impact of Dong Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Hua more than expected).

Fields of papers citing papers by Dong Hua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Hua. The network helps show where Dong Hua may publish in the future.

Co-authorship network of co-authors of Dong Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Hua. A scholar is included among the top collaborators of Dong Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Hua. Dong Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer 2020 ·Cancer Medicine ·Tingting Hong, Dongyan Cai, Linfang Jin, Ying Zhang, Tingxun Lu, Dong Hua, Xiaohong Wu	13
2	Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer 2019 ·Frontiers in Oncology ·(unknown), (unknown), Yu Tian, Ting Zhang, (unknown), (unknown), Yuan Yin, Dong Hua, Xiaowei Qi, Yong Mao	22
3	Serum miR-16 as a potential biomarker for human cancer diagnosis: results from a large-scale population 2019 ·Journal of Cancer Research and Clinical Oncology ·Zebo Huang, (unknown), Yiping Du, Qin Guo, Yong Mao, Xin Zhou, Dong Hua	24
4	Analysis of prognosis and influencing factors of CT-guided 125I radioactive seed implantation combined with chemotherapy for limited-stage small cell lung cancer 2018 ·Zhonghua fangshe yixue yu fanghu zazhi ·(unknown), Xiaodong Huo, Bin Huo, Dong Hua, (unknown), (unknown), (unknown), Junjie Wang, Haitao Wang, (unknown)	0
5	Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients 2018 ·Molecular Immunology ·Yong Mao, Cheng Wang, Fanyi Meng, (unknown), (unknown), Yiguo Jiang, Weipeng Wang, Dong Hua	1
6	The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6 2017 ·Clinical Cancer Research ·Yuan Yin, Surui Yao, Yaling Hu, Yuyang Feng, Min Li, Zehua Bian, Jiwei Zhang, Yan Qin, Xiaowei Qi, Leyuan Zhou, Bojian Fei, Jian Zou, Dong Hua, Zhaohui Huang	208
7	The application of technetium-99m-red blood cell scintigraphy in the diagnosis of orbital cavernous hemangioma 2017 ·Nuclear Medicine Communications ·Dong Hua, (unknown), (unknown), Hong Zhang, Wengui Xu	5
8	Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression 2017 ·Oncotarget ·Qi Chen, Yong Mao, Fanyi Meng, Lei Wang, (unknown), Weipeng Wang, Dong Hua	16
9	B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway 2016 ·Tumor Biology ·Bo Jiang, Fen Liu, (unknown), Ting Zhang, Dong Hua	31
10	Increasing circulating exosomes‐carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients 2016 ·Cancer Science ·Teng Wang, Kuan Ning, Tingxun Lu, (unknown), Linfang Jin, Xiaowei Qi, Jian Jin, Dong Hua	78
11	Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway 2015 ·International Journal of Immunopathology and Pharmacology ·Feng Wang, Yong Mao, Qingjun You, Dong Hua, Dongyan Cai	93
12	miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A 2014 ·Clinical Cancer Research ·Yuan Yin, Bin-Bin Zhang, Weili Wang, Bojian Fei, Chao Quan, Jiwei Zhang, Mingxu Song, Zehua Bian, Qifeng Wang, Shujuan Ni, Yaling Hu, Yong Mao, Leyuan Zhou, Yugang Wang, Jian Yu, Xiang Du, Dong Hua, Zhaohui Huang	169
13	MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer 2014 ·Human Immunology ·Jianjie Zhu, (unknown), (unknown), (unknown), (unknown), Yong Mao, Huan Zhou, Rui Li, (unknown), Weipeng Wang, Dong Hua, Xueguang Zhang	147
14	MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A 2014 ·Medical Oncology ·Bin-Bin Zhang, Yuan Yin, Yaling Hu, Jiwei Zhang, Zehua Bian, Mingxu Song, Dong Hua, Zhaohui Huang	86
15	A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population 2014 ·Medical Oncology ·(unknown), Fuchao Li, Jianjie Zhu, Rong Tang, Qinghua Qi, Xinru Zhou, (unknown), Weipeng Wang, Dong Hua, Weichang Chen	25
16	Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibility to colorectal cancer 2014 ·Cellular Immunology ·(unknown), Rong Tang, Qinghua Qi, Xinru Zhou, Huan Zhou, Yong Mao, Rui Li, Cuiping Liu, Weipeng Wang, Dong Hua, Xueguang Zhang	32
17	MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1 2014 ·Protein & Cell ·Mingxu Song, Yuan Yin, Jiwei Zhang, Binbin Zhang, Zehua Bian, Chao Quan, Leyuan Zhou, Yaling Hu, Qifeng Wang, Shujuan Ni, Bojian Fei, Weili Wang, Xiang Du, Dong Hua, Zhaohui Huang	76
18	MicroRNA-215 inhibits relapse of colorectal cancer patients following radical surgery 2013 ·Medical Oncology ·(unknown), Jing Gao, Jin Gu, Jiajia Yuan, Dong Hua, Lin Shen	34
19	A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding 2011 ·Human Mutation ·Weipeng Wang, Jing Sun, Fang Li, Rui Li, Yongping Gu, Cuiping Liu, (unknown), (unknown), Lujun Chen, Wenyan Tian, (unknown), Yong Mao, Liang Zhang, Jingting Jiang, Changping Wu, Dong Hua, Weichang Chen, Binfeng Lu, Jingfang Ju, Xueguang Zhang	81
20	Effect of low molecular weight heparin on growth,metastasis,and CXCR4 expression of orthotopicly transplanted gastric tumor in nude mice 2010 ·Tumori ·Dong Hua	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact